Using the 21‐gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial

201795 citationsJournal Article

Authors

Using the RS to guide NST is feasible. These results suggest that for patients with RS < 25 NHT is a potentially effective strategy.

Good health and well-being

Published in: Journal of Surgical Oncology

Volume 115, Issue 8, pp. 917-923

Field-Weighted Citation Impact: 2.56